Y&R Capital

Y&R Capital, established in May 2015, is a venture capital firm based in Beijing, China, focused on high-tech incubation and service management. It was jointly founded by Zhejiang Ganzhan Investment Management Co., Ltd. and Beijing Bochuang Xingsheng Technology Co., Ltd. The firm emphasizes investment in strategic emerging industries, particularly in the fields of medical health, artificial intelligence, robotics, and intelligent manufacturing. Y&R Capital aims to identify and support innovative companies that exhibit growth potential in these sectors, aligning its investment strategy with the evolving technological landscape.

Ruijun Zhang Ph.D

Founding Partner and CEO

Past deals in Eastern Asia

Beijing Weiying Technology

Series A in 2022
Founded in 2014 by David Lim, Beijing Weiying Technology specializes in developing and operating the online movie ticket booking platform 'WePiao', integrated within WeChat. Collaborating with over 2000 cinemas nationwide, including Wanda's chains, the company aims to expand its services to other entertainment sectors such as performances and sports events.

Atomrobot

Series B in 2019
Atomrobot specializes in the manufacture of industrial robots and the provision of production line system solutions. The company is dedicated to delivering standalone machines and workstations tailored for various industries, including food, pharmaceuticals, and daily chemicals. By enhancing production capacity and performance, Atomrobot aims to reduce reliance on manual labor, thereby addressing the needs of China's large blue-collar workforce. Its high-end parallel robot brand, Astro Boy, is noted for its exceptional machine performance, operational reliability, and extensive field experience. Atomrobot has successfully expanded its market reach, becoming a pioneer in exporting domestic robots to international markets such as the UK and Russia.

Atomrobot

Series B in 2019
Atomrobot specializes in the manufacture of industrial robots and the provision of production line system solutions. The company is dedicated to delivering standalone machines and workstations tailored for various industries, including food, pharmaceuticals, and daily chemicals. By enhancing production capacity and performance, Atomrobot aims to reduce reliance on manual labor, thereby addressing the needs of China's large blue-collar workforce. Its high-end parallel robot brand, Astro Boy, is noted for its exceptional machine performance, operational reliability, and extensive field experience. Atomrobot has successfully expanded its market reach, becoming a pioneer in exporting domestic robots to international markets such as the UK and Russia.

Arrays Medical Imaging

Series B in 2017
Beijing Arrays Medical Imaging Corporation specializes in the development, production, and sales of advanced medical molecular imaging devices. The company is known for its multi-modality imaging technologies, which are essential for diagnosing cancer, brain, and heart diseases. Its flagship product, the RAYSCAN-64 PET/CT scanner, integrates positron emission tomography (PET) and computed tomography (CT) to deliver high-quality, clear images that enhance disease diagnosis. This innovative device combines the functional imaging capabilities of PET with the anatomical detail provided by CT, achieving performance characteristics comparable to or exceeding those of similar international products. The RAYSCAN-64 PET/CT scanner has undergone clinical validation and has received positive feedback from medical professionals, demonstrating its effectiveness in supporting the diagnostic needs of healthcare practitioners.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.